These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9851186)

  • 21. Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats.
    Aguilar MA; Miñarro J; Felipo V
    Exp Neurol; 2000 Feb; 161(2):704-13. PubMed ID: 10686089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiopathic hyperammonemia following an unrelated cord blood transplant for mucopolysaccharidosis I.
    Snyder MJ; Bradford WD; Kishnani PS; Hale LP
    Pediatr Dev Pathol; 2003; 6(1):78-83. PubMed ID: 12481230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe acute hyperammonemia after brief exposure to valproate.
    Eubanks AL; Aguirre B; Bourgeois JA
    Psychosomatics; 2008; 49(1):82-3. PubMed ID: 18212182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma.
    Ribatti D; Nico B; Vacca A
    Oncogene; 2006 Jul; 25(31):4257-66. PubMed ID: 16518413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
    Mallet L; Babin S; Morais JA
    Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple myeloma: recognition and management.
    George ED; Sadovsky R
    Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple myeloma: primary bone tumor with systemic manifestations.
    Bilsky MH; Azeem S
    Neurosurg Clin N Am; 2008 Jan; 19(1):31-40. PubMed ID: 18156045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Myelomatosis and low level of vitamin B12].
    Heyerdahl F; Kildahl-Andersen O
    Tidsskr Nor Laegeforen; 1999 Nov; 119(29):4321-2. PubMed ID: 10667130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple myeloma. Preface.
    Anderson KC
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):xiii-xiv. PubMed ID: 17996584
    [No Abstract]   [Full Text] [Related]  

  • 30. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
    Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
    Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperammonemic encephalopathy in multiple myeloma.
    Furer V; Heyd J
    Isr Med Assoc J; 2007 Jul; 9(7):557-9. PubMed ID: 17710792
    [No Abstract]   [Full Text] [Related]  

  • 32. Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib.
    Anargyrou K; Terpos E; Vassilakopoulos TP; Pouli A; Sachanas S; Tzenou T; Masouridis S; Christoulas D; Angelopoulou MK; Dimitriadou EM; Kalpadakis C; Tsionos K; Panayiotidis P; Dimopoulos MA; Pangalis GA; Kyrtsonis MC;
    Haematologica; 2008 Mar; 93(3):451-4. PubMed ID: 18287135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thalidomide metabolites in mice and patients with multiple myeloma.
    Lu J; Palmer BD; Kestell P; Browett P; Baguley BC; Muller G; Ching LM
    Clin Cancer Res; 2003 May; 9(5):1680-8. PubMed ID: 12738721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wnt antagonism in multiple myeloma: a potential cause of uncoupled bone remodeling.
    Pearse RN
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6274s-6278s. PubMed ID: 17062713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperammonemia during hypothyroidism: an unusual biohumoral finding normalized by hormonal replacement treatment].
    De Nardo D; Franconi G; Sabino D
    Ann Ital Med Int; 1999; 14(3):196-201. PubMed ID: 10566186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal gammopathy of undetermined significance: new insights.
    Chen BH
    CMAJ; 2002 May; 166(10):1309. PubMed ID: 12041852
    [No Abstract]   [Full Text] [Related]  

  • 37. Skeletal tissue remodeling in multiple myeloma.
    Borset M
    Haematologica; 2006 Feb; 91(2):147b. PubMed ID: 16461293
    [No Abstract]   [Full Text] [Related]  

  • 38. [Multiple myeloma: the role of angiogenesis and therapeutic application of thalidomide].
    Jurczyszyn A; Wolska-Smoleń T; Skotnicki AB
    Przegl Lek; 2003; 60(8):542-7. PubMed ID: 14974349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inherited hyperammonemia].
    Bik-Multanowski M
    Przegl Lek; 1998; 55(6):337-41. PubMed ID: 9857711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights into the biology and advances in the management of multiple myeloma.
    Harousseau JL
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):569-70. PubMed ID: 18070706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.